Viewing Study NCT06094868


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2025-12-28 @ 4:44 AM
Study NCT ID: NCT06094868
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-10-23
First Post: 2023-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study of Fruquintinib Combined With Sintilimab and XELOX Regimen in the Treatment of Advanced Cancer
Sponsor: Second Affiliated Hospital of Nanchang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module